NetworkNewsBreaks – Pressure BioSciences Inc. (P
Post# of 1354
(Total Views: 95)
Posted On: 05/25/2018 7:17:04 PM
NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Reports Increase in Revenue, Debt Conversion in Q1 2018
Global life sciences company Pressure BioSciences (OTCQB: PBIO) recently announced financial results for the first quarter ended March 31, 2018. Among other highlights, the company reported first quarter revenue growth and debenture conversion. An article discussing the report further reads: “The first quarter of 2018 was the ninth consecutive quarter in which the company reported an increase in products and services revenue on a year-over-year basis and the second time during the past year in which the company reported total quarterly revenue of more than $600,000. Sales of the company’s instruments established a new quarterly record, and sales of the instruments’ consumable elements increased by 18 percent following on a 21 percent revenue increase for the final quarter of 2017. … In addition to the revenue achievements, the company reported that, operationally, it was advancing in its relationships with clients as a new cadre of sales directors began working in their assigned geographical areas.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Global life sciences company Pressure BioSciences (OTCQB: PBIO) recently announced financial results for the first quarter ended March 31, 2018. Among other highlights, the company reported first quarter revenue growth and debenture conversion. An article discussing the report further reads: “The first quarter of 2018 was the ninth consecutive quarter in which the company reported an increase in products and services revenue on a year-over-year basis and the second time during the past year in which the company reported total quarterly revenue of more than $600,000. Sales of the company’s instruments established a new quarterly record, and sales of the instruments’ consumable elements increased by 18 percent following on a 21 percent revenue increase for the final quarter of 2017. … In addition to the revenue achievements, the company reported that, operationally, it was advancing in its relationships with clients as a new cadre of sales directors began working in their assigned geographical areas.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Pressure Biosciences (PBIO) Stock Research Links
Scroll down for more posts ▼